Atlas Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$655K Sell
2,579
-250
-9% -$58.3K 0.72% 24
2026
Q1
$692K Sell
2,829
-123
-4% -$28.6K 0.71% 26
2025
Q4
$611K Sell
2,952
-50
-2% -$9.89K 0.67% 27
2025
Q3
$557K Sell
3,002
-125
-4% -$21.4K 0.57% 28
2025
Q2
$478K Sell
3,127
-425
-12% -$65.3K 0.55% 26
2025
Q1
$589K Sell
3,552
-370
-9% -$57.9K 0.73% 21
2024
Q4
$567K Sell
3,922
-150
-4% -$23.2K 0.72% 21
2024
Q3
$660K Buy
+4,072
New +$649K 1.01% 18
2023
Q3
Sell
-4,944
Closed -$841K 23
2023
Q2
$841K Buy
+4,944
New +$798K 2.42% 11

Other funds holding JNJ

Atlas Wealth Partners's JNJ Position: Q2 2026 in Review

Atlas Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 8.8% in Q2 2026, selling an estimated $58.3K and leaving 2,579 shares worth $655K. The position accounts for 0.72% of the portfolio, ranked #24.

Atlas Wealth Partners first reported a position in JNJ in Q2 2023 and has held it in 9 quarters since. The position peaked at $841K in Q2 2023. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Atlas Wealth Partners held 2,579 shares of Johnson & Johnson worth $655K as of Q2 2026.
  • Atlas Wealth Partners sold 250 Johnson & Johnson shares in Q2 2026, an estimated $58.3K.
  • Johnson & Johnson made up 0.72% of Atlas Wealth Partners's portfolio in Q2 2026, its #24 holding.
  • Atlas Wealth Partners first reported a position in Johnson & Johnson in Q2 2023 and has held it in 9 quarters since.
  • Atlas Wealth Partners's Johnson & Johnson position peaked at $841K in Q2 2023.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Atlas Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.